Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 23

1.

[The impact of exposure to cigarette smoke on the haemodynamic response during exercise of patients under specific treatment for pulmonary arterial hypertension].

Valentin S, Zysman M, Guillaumot A, Gomez E, Chabot F, Chaouat A.

Rev Mal Respir. 2020 Mar 18. pii: S0761-8425(20)30020-6. doi: 10.1016/j.rmr.2019.11.651. [Epub ahead of print] French.

PMID:
32199735
2.

[Woman's asthma throughout life: Towards a personalized management?]

Raherison C, Hamzaoui A, Nocent-Ejnaini C, Essari LA, Ouksel H, Zysman M, Prudhomme A; groupe de travail 'Femmes et poumons' de la SPLF.

Rev Mal Respir. 2020 Feb;37(2):144-160. doi: 10.1016/j.rmr.2019.07.013. Epub 2020 Feb 10. Review. French.

PMID:
32057504
3.

Relationship between gender and survival in a real-life cohort of patients with COPD.

Zysman M, Burgel PR, Court-Fortune I, Brinchault-Rabin G, Nesme-Meyer P, Surpas P, Deslée G, Perez T, Le Rouzic O, Jebrak G, Chanez P, Paillasseur JL, Caillaud D, Roche N; Initiatives BPCO scientific committee and investigators.

Respir Res. 2019 Aug 22;20(1):191. doi: 10.1186/s12931-019-1154-3.

4.

Predictors in routine practice of 6-min walking distance and oxygen desaturation in patients with COPD: impact of comorbidities.

Perez T, Deslée G, Burgel PR, Caillaud D, Le Rouzic O, Zysman M, Escamilla R, Jebrak G, Chanez P, Court-Fortune I, Brinchault-Rabin G, Nesme-Meyer P, Paillasseur JL, Roche N; Initiatives BPCO Scientific Committee.

Int J Chron Obstruct Pulmon Dis. 2019 Jul 2;14:1399-1410. doi: 10.2147/COPD.S188412. eCollection 2019.

5.

Prevalence and management of chronic breathlessness in COPD in a tertiary care center.

Carette H, Zysman M, Morelot-Panzini C, Perrin J, Gomez E, Guillaumot A, Burgel PR, Deslee G, Surpas P, Le Rouzic O, Perez T, Chaouat A, Roche N, Chabot F; Initiatives BPCO (bronchopneumopathie chronique obstructive) Scientific Committee and Investigators.

BMC Pulm Med. 2019 May 16;19(1):95. doi: 10.1186/s12890-019-0851-5.

6.

[Early determinants of chronic obstructive pulmonary disease: Lung regeneration, a new therapeutic target?]

Zysman M, Ribeiro Baptista B, Essari LA, Giffard C, Chabot F, Epaud R, Lanone S, Boczkowski J, Boyer L.

Rev Mal Respir. 2019 Apr;36(4):447-450. doi: 10.1016/j.rmr.2019.03.006. Epub 2019 Apr 19. Review. French.

PMID:
31010755
7.

[The impact of the patient's age on the delay of the lung cancer treatment].

Knoepfli A, Vaillant P, Billon Y, Zysman M, Menard O, Tiotiu A.

Bull Cancer. 2019 May;106(5):421-430. doi: 10.1016/j.bulcan.2019.02.010. Epub 2019 Apr 10. French.

PMID:
30981465
8.

[Evaluation of cardiac MRI in the follow up assessment of patients with pulmonary arterial hypertension].

Chaouat A, Cherifi A, Sitbon O, Girerd N, Zysman M, Faure M, Mandry D, Mercy M, Guillaumot A, Fay R, Marie PY, Chabot F.

Rev Mal Respir. 2018 Sep;35(7):749-758. doi: 10.1016/j.rmr.2018.01.010. Epub 2018 Jun 23. French.

PMID:
29945811
9.

Blood eosinophil counts as a guide for COPD treatment strategies.

Roche N, Zysman M, Burgel PR.

Lancet Respir Med. 2018 Feb;6(2):78-80. doi: 10.1016/S2213-2600(18)30005-5. Epub 2018 Jan 10. No abstract available.

PMID:
29331310
10.

Pharmacological treatment optimisation for stable COPD: an endless story? Proposals from the Société de Pneumologie de Langue Française.

Zysman M, Chabot F, Housset B, Morelot Panzini C, Devillier P, Roche N; Société de Pneumologie de Langue Française.

Eur Respir J. 2017 Oct 12;50(4). pii: 1701250. doi: 10.1183/13993003.01250-2017. Print 2017 Oct. No abstract available.

11.

[Complementary and alternative medicine use by lung cancer patients].

Rossanaly Vasram R, Zysman M, Ribeiro Baptista B, Ederle C, Nguyen-Thi PL, Clement-Duchene C, Martinet Y.

Rev Pneumol Clin. 2017 Sep;73(4):172-179. doi: 10.1016/j.pneumo.2017.04.002. Epub 2017 Jul 26. French.

PMID:
28756003
12.

Relationship between blood eosinophils, clinical characteristics, and mortality in patients with COPD.

Zysman M, Deslee G, Caillaud D, Chanez P, Escamilla R, Court-Fortune I, Nesme-Meyer P, Perez T, Paillasseur JL, Pinet C, Jebrak G, Roche N, Burgel PR.

Int J Chron Obstruct Pulmon Dis. 2017 Jun 20;12:1819-1824. doi: 10.2147/COPD.S129787. eCollection 2017.

13.

Erratum to "Pharmacological treatment optimization for stable chronic obstructive pulmonary disease. Proposals from the Société de pneumologie de langue française" [Rev. Mal. Respir. 33 (2016) 911-936].

Zysman M, Chabot F, Devillier P, Housset B, Morelot-Panzini C, Roche N; pour la Société de pneumologie de langue française (SPLF).

Rev Mal Respir. 2017 Feb;34(2):175-176. doi: 10.1016/j.rmr.2017.01.005. Epub 2017 Feb 23. No abstract available.

PMID:
28237069
14.

Pharmacological treatment optimization for stable chronic obstructive pulmonary disease. Proposals from the Société de Pneumologie de Langue Française.

Zysman M, Chabot F, Devillier P, Housset B, Morelot-Panzini C, Roche N; Société de Pneumologie de Langue Française (SPLF).

Rev Mal Respir. 2016 Dec;33(10):911-936. doi: 10.1016/j.rmr.2016.10.004. Epub 2016 Nov 25. Review. Erratum in: Rev Mal Respir. 2017 Feb;34(2):175-176.

PMID:
27890625
15.

[Malignant rhabdoid tumor of the lung].

Zysman M, Clement-Duchene C, Bastien C, Vaillant P, Martinet Y.

Rev Mal Respir. 2016 Nov;33(9):808-811. doi: 10.1016/j.rmr.2015.09.011. Epub 2016 Aug 29. French.

PMID:
27595391
16.

Lack of Transcription Factor p53 Exacerbates Elastase-Induced Emphysema in Mice.

Chrusciel S, Zysman M, Caramelle P, Tiendrebeogo A, Baskara I, Le Gouvello S, Chabot F, Giraudier S, Boczkowski J, Boyer L.

Am J Respir Cell Mol Biol. 2016 Feb;54(2):188-99. doi: 10.1165/rcmb.2014-0375OC.

PMID:
26106979
17.

[Impact of COPD: from disability to exacerbations].

Chabot F, Zysman M, Perrin J, Mercy M, Guillaumot A, Gomez E, Kheir A, Chaouat A.

Presse Med. 2014 Dec;43(12 Pt 1):1353-8. doi: 10.1016/j.lpm.2014.08.009. Epub 2014 Oct 29. Review. French.

PMID:
25448123
18.

[Epidemiology and COPD screening in France. Workshop from the Société de Pneumologie de Langue Française (SPLF)].

Patout M, Zysman M, Raherison Semjen C, Perez T, Cuvelier A, Roche N.

Rev Mal Respir. 2014 Oct;31(8):693-9. doi: 10.1016/j.rmr.2014.05.003. Epub 2014 Jul 8. Review. French.

PMID:
25391504
19.

[COPD and perception of the new GOLD document in Europe. Workshop from the Société de pneumologie de langue française (SPLF)].

Zysman M, Patout M, Miravitlles M, van der Molen T, Lokke A, Hausen T, Didier A, Cuvelier A, Roche N.

Rev Mal Respir. 2014 Jun;31(6):499-510. doi: 10.1016/j.rmr.2014.02.014. Epub 2014 May 9. Review. French.

PMID:
25012036
20.

[Evaluation of requests for a second medical opinion by patients with lung cancer].

Zysman M, Clément-Duchène C, Nguyen-Thi PL, Carnin C, Martinet Y.

Rev Mal Respir. 2014 May;31(5):412-20. doi: 10.1016/j.rmr.2013.09.004. Epub 2013 Oct 18. French.

PMID:
24878157
21.

[Combined pulmonary fibrosis and emphysema: the natural history of the disease. The chronological evolution of clinical features, respiratory function and the CT scan].

Ponçot-Mongars R, Zysman M, Regent D, Gomez E, Chaouat A, Chabot F.

Rev Mal Respir. 2013 Mar;30(3):222-6. doi: 10.1016/j.rmr.2012.06.002. Epub 2012 Jul 23. French.

PMID:
23497932
22.
23.

Considerations when analyzing the methylation status of PTEN tumor suppressor gene.

Zysman MA, Chapman WB, Bapat B.

Am J Pathol. 2002 Mar;160(3):795-800. Erratum in: Am J Pathol 2002 Jun;160(6):2311.

Supplemental Content

Loading ...
Support Center